 | Up a level |
van der Meer, A. J.; Veldt, B. J.; Feld, J. J.; Wedemeyer, H.; Dufour, Jean-François; Lammert, F.; Duarte-Rojo, A.; Manns, M. P.; Zeuzem, S.; Hofmann, W. P.; de Knegt, R. J.; Hansen, B. E.; Janssen, H. L. A. (2013). The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection. Journal of viral hepatitis, 21(8), pp. 568-577. Blackwell Science 10.1111/jvh.12185
Robaeys, G.; Grebely, J.; Mauss, S.; Bruggmann, P.; Moussalli, J.; De Gottardi, Andrea; Swan, T.; Arain, A.; Kautz, A.; Stover, H.; Wedemeyer, H.; Schaefer, M.; Taylor, L.; Backmund, M.; Dalgard, O.; Prins, M.; Dore, G. J. (2013). Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Clinical infectious diseases, 57(Suppl 2), S129-S137. Oxford University Press 10.1093/cid/cit302
